"First in Man" Total Percutaneous Aortic Arch Repair With 3-Inner-branch Endografts: A Report of Two Cases.

医学 外科 主动脉弓 经皮 动脉瘤 解剖(医学) 主动脉夹层 支架 体外循环 主动脉瘤 放射科
作者
Justine Mougin,Ron Azogui,Julien Guihaire,Mark R Tyrrell,Gustavo S Oderich,Dominique Fabre,Stéphan Haulon
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:274 (6): e652-e657
标识
DOI:10.1097/sla.0000000000005167
摘要

Aneurysms of the arch are a complex clinical problem and a technical challenge. Currently, over 40% of patients are considered unfit for conventional open surgery, requiring a cardiopulmonary bypass and hypothermic circulatory arrest. In experienced hands and appropriate anatomic conditions, arch-branched graft technology has shown to be a safe and effective alternative to open conventional surgery to patients that historically have had no surgical options.This report summarizes the first in man implant of a three-vessel arch branch stent graft using a total percutaneous approach without the need for exposure of the cervical arteries-a surgical step with inherent problems and risks.This approach was performed in two consecutive patients, a 66-year-old woman with a chronic post type A dissection 60 mm diameter aneurysm of the aortic arch, and a 72-year-old man with a 70 mm saccular degenerative atheromatous aortic arch aneurysm.Technical success was obtained in both cases. The patients were extubated in the operating theatre. Neither suffered any pre- or postoperative neurological deficits. Both were discharged home after remarkably uneventful hospital stays. There were no access complications. Postoperative computerized tomography scans and ultra-sound confirmed patent supra-aortic branches and completely excluded aneurysms.Our new truly minimally invasive approach demonstrates that it is possible to manage one of the most challenging treatments of aortic pathologies without any surgical incision. Further, evaluation and experience are required to confirm these promising results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lee1992发布了新的文献求助10
刚刚
1秒前
认真的砖头完成签到 ,获得积分10
1秒前
最爱喝酸奶完成签到,获得积分10
1秒前
蔺不平完成签到,获得积分10
2秒前
2秒前
MAR完成签到,获得积分10
2秒前
2秒前
浮游应助学吧采纳,获得10
2秒前
打打应助强哥采纳,获得10
2秒前
江南逢李龟年完成签到,获得积分10
3秒前
斯文雪青完成签到,获得积分10
3秒前
小蘑菇应助学术废物采纳,获得10
3秒前
困屁鱼发布了新的文献求助50
3秒前
俭朴尔竹发布了新的文献求助10
3秒前
桐桐应助北岭梅花香到骨采纳,获得10
3秒前
激昂的幻梦完成签到,获得积分10
4秒前
May完成签到,获得积分10
4秒前
花藏影完成签到,获得积分10
4秒前
吴彦祖完成签到,获得积分10
4秒前
4秒前
sevenhill应助大傻春采纳,获得10
4秒前
典雅黑夜发布了新的文献求助10
4秒前
Suzzne完成签到,获得积分10
4秒前
对镜贴花应助刘佳宇采纳,获得10
4秒前
4秒前
lujiajia发布了新的文献求助10
5秒前
5秒前
852应助咕噜采纳,获得10
6秒前
YouziBa完成签到,获得积分10
6秒前
123发布了新的文献求助10
6秒前
辛勤谷雪完成签到,获得积分0
7秒前
fdawn完成签到,获得积分10
8秒前
lanheqingniao完成签到,获得积分10
8秒前
Microbiota完成签到,获得积分10
8秒前
miao3718完成签到 ,获得积分10
8秒前
顺利的藏今完成签到,获得积分10
8秒前
8秒前
坦率的海豚完成签到,获得积分10
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
化妆品原料学 1000
小学科学课程与教学 500
Study and Interlaboratory Validation of Simultaneous LC-MS/MS Method for Food Allergens Using Model Processed Foods 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5645431
求助须知:如何正确求助?哪些是违规求助? 4768803
关于积分的说明 15028908
捐赠科研通 4804012
什么是DOI,文献DOI怎么找? 2568656
邀请新用户注册赠送积分活动 1525914
关于科研通互助平台的介绍 1485570